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Abstract: Background: The FUT2 gene (Se gene) encoding the enzyme α-1,2-L-fucosyltransferase
2 seems to have a significant effect on the number and type of bacteria colonizing the intestines.
Methods: In a group of 19 patients after bariatric surgery, the polymorphism (rs601338) of FUT2 gene
was analyzed in combination with body mass reduction, intestinal microbiome (16S RNA sequencing),
and short chain fatty acids (SCFA) measurements in stools. Results: Among the secretors (Se/Se
polymorphism of the FUT2 gene rs601338, carriers of GG variant), correlations between waist-hip ratio
(WHR) and propionate content and an increase in Prevotella, Escherichia, Shigella, and Bacteroides were
observed. On the other hand—in non-secretors (carriers of GA and AA variants)—higher abundance
of Enterobacteriaceae, Ruminococcaceae, Enterobacteriaceae, Clostridiales was recorded. Conclusions:
The increased concentrations of propionate observed among the GG variants of FUT 2 may be used
as an additional source of energy for the patient and may have a higher risk of increasing the WHR
than carriers of the other variants (GA and AA).
Keywords: bariatric surgery; obesity; Roux-en-Y gastric bypass; sleeve gastrectomy; microbiota;
short-chain fatty acids; FUT2 gene; propionate; waist-hip ratio

1. Introduction
The number of patients with severe obesity is gradually increasing. With relation to conservative
treatments, bariatric surgery is considered to be a more effective way of treating patients with severe
obesity, leading to reduction in both weight and coexisting diseases and mortality [1]. According
to the American Society for Metabolic and Bariatric Surgery, the number of metabolic and bariatric
procedures performed in 2018 was 10.8% higher than in 2017; only approximately 1% of all patients
who qualify for bariatric surgery actually undergo surgery [2].
One of the factors that may be involved in the pathogenesis of severe obesity is intestinal microbiota.
The mechanism includes changes in the composition of intestinal bacteria described as intestinal
dysbiosis (disturbed relation between Bacteroidetes and Firmicutes types) generating inflammation [3].
Nutrients 2020, 12, 2621; doi:10.3390/nu12092621
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Systematic reviews have shown that bariatric surgeries affect the human microbiome. Microbial
richness increases significantly within 3 months and is maintained after 1 to 2 years post-surgery.
Greater alterations in the microbiome occur after Roux-en-Y gastric bypass, than after purely restrictive
bariatric procedures (e.g., sleeve gastrectomy). An increase in Bacteroidetes and Proteobacteria and a
decrease in Firmicutes post-bariatric surgery are observed. These changes induce an increase of the
Bacteroides/Firmicutes ratio, which are positively associated with weight loss post-bariatric surgery [4].
The FUT2 gene, or Se gene, codes the enzyme α-1,2-L-fucosyltransferase 2 and conditions the
formation of H antigens in the intestinal epithelial tissue [5]. Individuals with at least one Se allele
(Se/Se or Se/se genotypes) have ABO and H system antigens on epithelial cells and are called secretors
(variant G428A (se428, W143X, rs601338). In contrast, homozygotes for FUT2 AA (se/se, The FUT2-AAA
(G428A, W143X)), are called non-secretors [6–8], which means they are unable to secrete histo-blood
group antigens into bodily fluids, or express them on mucosal surfaces [9]. FUT2 (rs601338, G428A)
is the most common polymorphism in FUT2 Caucasian non-secretors [5]. When the FUT 2 gene
is expressed in the intestines, the antigens encoded by this gene participate in the anchorage of
various intestinal bacteria [10]. It seems that the type of the FUT2 gene allele may be one of the main
determinants of bacteria colonizing the intestines [8].
Studies have shown that FUT2 gene expression may be influenced by intestinal microbiota, e.g.,
in response to infection risk [5,11,12]. Symbiotic bacteria may induce a signaling cascade leading to
increased expression of the FUT2 gene, thus modulating colonization of the gastrointestinal tract by
other microorganisms [12].
Comparing the overall number and diversity of intestinal microbiota, it is indicated that
non-secretors have significantly lower diversity (the number of microbial genes was less by 15% on
average) [13]. The basic difference between Se/Se and se/se genotypes is the number of Bifidobacterium
bacteria. This genus is significantly less abundant among non-secretors (AA). Among the non-secretors,
a lower number microorganisms producing short chain fatty acids, including anti-inflammatory
butyrate (e.g., Roseburia intestinales), was also identified [13,14]. In addition, a different number of
Lactobacillus and Clostridium bacteria is observed in secretors compared to non-secretors [15].
Carbohydrates that are not digested in the stomach are transferred to the small and large intestine,
where they are used by intestinal microbiota that ferment them to short chain fatty acids (SCFA).
Acetate, propionate, and butyrate are produced in the intestines. SCFA can act as an intermediary in
controlling energy consumption. Activation of the orphan GPR41 receptor by propionate can have an
appetite suppressant effect as propionate stimulates leptin synthesis [16,17].
The aim of the study was to determine whether variants of the FUT2 gene may be responsible
for differences in the profile of intestinal microbiota in patients undergoing bariatric surgery who
developed depressive disorders. The hypothesis we wanted to verify included the assumption that
people with variants of Se/Se and Se/se of the FUT2 gene through increased number of bacteria involved
in the SCFA synthesis process and probable higher SCFA synthesis will have higher body weight
compared to “non-secreting” people (se/se FUT2) [18].
2. Materials and Methods
2.1. Study Area
The study was attended by patients who were after bariatric surgery and had depressive disorders.
In the literature, there are reports of the development of mental disorders in some patients after
surgery [19,20], although this group has been relatively little studied.
Patients were recruited at the Surgical Obesity Surgery Outpatient Clinic in Szczecin Zdunowo,
Poland between July 2018 and March 2019. At the outpatient clinic, all patients (n = 117) who underwent
Sleeve gastrectomy or Roux-en-Y gastric bypass surgery in at least the last 6 months were asked to fill
in the Beck scale. In this study, out of 117 interviewed individuals, 49 met the criteria for inclusion
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Metabolomics of Pomeranian Medical University in Szczecin and a fecal sample was collected
and frozen at −80 ◦ C until analysis. On-site anthropometric measurements, a food frequency
Individuals qualified for the study were enrolled in the Department of Human Nutrition and
questionnaire supplemented with questions on the type of bariatric surgery, weight reduction after
Metabolomics of Pomeranian Medical University in Szczecin and a fecal sample was collected and
surgery, the supplementation used, and drugs used, as well as the occurrence of diseases and ailments
frozen at −80 °C until analysis. On‐site anthropometric measurements, a food frequency
(i.e., abdominal pain, nausea, vomiting, heartburn, constipation, diarrhea) were given. Additionally,
questionnaire supplemented with questions on the type of bariatric surgery, weight reduction after
the patient’s dietary reports from 72 h were collected and analyzed with the use of the 5D diet program.
surgery, the supplementation used, and drugs used, as well as the occurrence of diseases and
In order to obtain material for genetic testing, a blood sample was taken.
ailments (i.e., abdominal pain, nausea, vomiting, heartburn, constipation, diarrhea) were given.
All subjects gave their informed consent for inclusion before they participated in the study.
Additionally, the patient’s dietary reports from 72 h were collected and analyzed with the use of the
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
5D diet program. In order to obtain material for genetic testing, a blood sample was taken.
approved by the Ethics Committee of Pomeranian Medical University in Szczecin (No KB-0012/40/17).
All subjects gave their informed consent for inclusion before they participated in the study. The
A prospective observational study was carried out in individuals who were at least 6 months after
study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved
bariatric operation (performed with the sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB)).
by the Ethics Committee of Pomeranian Medical University in Szczecin (No KB‐0012/40/17). A
The inclusion criterion for the study group included the determination of depressive disorders using
prospective observational study was carried out in individuals who were at least 6 months after
the Beck scale (≥12 points) [21,22]. All participants declared that they did not take antidepressants.
bariatric operation (performed with the sleeve gastrectomy (SG) or Roux‐en‐Y gastric bypass
The exclusion criteria included the use of non-steroidal anti-inflammatory drugs, antibiotics, probiotics,
(RYGB)). The inclusion criterion for the study group included the determination of depressive
and proton pump inhibitors during the 6 months preceding the start of the study.
disorders using the Beck scale (≥12 points) [21,22]. All participants declared that they did not take
antidepressants.
exclusion criteria
2.2. Study Protocol,The
the Anthropometric
Dataincluded the use of non‐steroidal anti‐inflammatory drugs,
antibiotics, probiotics, and proton pump inhibitors during the 6 months preceding the start of the
During the check-up visit, anthropometric data were collected. Using a medical tape, hip and waist
study.
circumference was measured. Based on these measurements, waist-hip ratio (WHR) was calculated
(WHR
= waist
circumference
(cm)/hipData
circumference (cm)), body mass index (BMI) was calculated
2.2. Study
Protocol,
the Anthropometric
according to these measurements (Body mass index BMI = body weight (kg)/square of height (m))
During the check‐up visit, anthropometric data were collected. Using a medical tape, hip and
(Table 1 and Figure 2).
waist circumference was measured. Based on these measurements, waist‐hip ratio (WHR) was
calculated (WHR = waist circumference (cm)/hip circumference (cm)), body mass index (BMI) was
calculated according to these measurements (Body mass index BMI = body weight (kg)/square of
height (m)) (Table 1 and Figure 2).
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Feature
Age (years)
Age (years)

46.3 (±11.7)

Type of surgery

Type of surgery

Weight
before
Weight before
surgery
(kg) surgery (kg)
BMI
before
(kg/m2 )
2)
BMI before surgery (kg/msurgery
Post-operative
Post‐operative
period (years)period (years)
Actual
Actual weight
(kg) weight (kg)
2
Actual BMI Actual
(kg/m2) BMI (kg/m )
Actual
waist
circumference
(cm)
Actual waist circumference (cm)
Actual WHRActual WHR

46.3 (±11.7)
10 patients Roux-en-Y gastric bypass (RYGB)
10 patients Roux‐en‐Y gastric bypass (RYGB)
9 patients sleeve gastrectomy (SG)
9 patients sleeve gastrectomy (SG)
122.3
(±22.1)
122.3
(±22.1)
43.2
(±5.9)
43.2 (±5.9)
(±3.4)
3.23.2
(±3.4)
95.5
(±23.5)
95.5
(±23.5)
30.6
(±5.3)
30.6
(±5.3)
94.2(±12.2)
94.2(±12.2)
0.82
(±0.07)
0.82
(±0.07)

±±standard
deviation.
standard deviation.

Figure 2. Body weight of FUT2 variants.
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polymorphism rs 601338 of the FUT2 gene. The genetic material was amplified in real-time polymerase
A method based on quantitative DNA polymerase chain reaction (qPCR) was used to evaluate
chain reaction with LightCycler® 96 (Roche). Genotyping was performed according to the TaqMan
the polymorphism rs 601338 of the FUT2 gene. The genetic material was amplified in real‐time
method using 10 ng of DNA. The reaction mixture was TaqMan Genotyping Master Mix (catalogue
polymerase chain reaction with LightCycler®96 (Roche). Genotyping was performed according to the
number: 437135, Thermo Fisher Scientific, Foster City, CA, USA) and oligonucleotide TaqMan SNP
TaqMan method using 10 ng of DNA. The reaction mixture was TaqMan Genotyping Master Mix
Genotyping Assays (Applied Biosystems, Thermo Fisher Scientific, Foster City, CA, USA).
(catalogue number: 437135, Thermo Fisher Scientific, Foster City, CA, USA) and oligonucleotide
TaqMan
Genotyping
Biosystems,
Thermo
Fisher Scientific, Foster City, CA,
2.4. DNASNP
Extraction
and the Assays
Analysis(Applied
of Bacterial
16S RNA Gene
Sequencing
USA).
DNA extraction and sequencing of the regions V1–V2 of the 16S r DNA gene on Illumina
MiSeq
(Illumina
Inc,
San
CA,
USA) were
performed
at the Institute of Clinical Molecular
2.4. DNA
Extraction
and
theDiego,
Analysis
of Bacterial
16S RNA
Gene Sequencing
Biology in Kiel University (Kiel, Germany) by their in-house protocol. DNA isolation was carried out
extraction
and Fast
sequencing
of the
V1–V2
16S r DNA
gene on
Illumina
MiSeq
usingDNA
the QIAamp
DNA
Stool Mini
Kitregions
automated
on of
thethe
QIAcube
(Qiagen,
Hilden,
Germany).
(Illumina
Inc,
San
Diego,
CA,
USA)
were
performed
at
the
Institute
of
Clinical
Molecular
Biology
in
The samples were transferred to 0.70 mm Garnet Bead Tubes (Dianova, Hamburg, Germany) and were
Kiel
University
(Kiel,
Germany)
by and
theirbead
in‐house
protocol.
DNA
isolation PLUS
was carried
out Jena,
usingJena,
the
subjected
to 1.1 mL
ASL
lysis buffer
beating
using the
a SpeedMill
(Analytik
QIAamp
DNA
Fast
Stool
Mini
Kit
automated
on
the
QIAcube
(Qiagen,
Hilden,
Germany).
The
◦
Germany) for 45 s at 50 Hz. After this step, samples were heated to 95 C for 5 min. Further analysis
samples were
transferred
0.70 mm Garnet
Bead Tubes (Dianova,
Hamburg,
Germany)
and were
proceeded
according
to thetomanufacturer’s
recommendations.
The acquired
DNA
concentration
was
subjected
to
1.1
mL
ASL
lysis
buffer
and
bead
beating
using
the
a
SpeedMill
PLUS
(Analytik
Jena,
10–40 µg/sample.
Jena, Germany) for 45 s at 50 Hz. After this step, samples were heated to 95 °C for 5 min. Further
analysis proceeded according to the manufacturer’s recommendations. The acquired DNA
concentration was 10–40 μg/sample.
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For amplification, we applied 3 µL of DNA, dilution 1:10. PCR products were analyzed by agarose gel
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v3 2×300bp
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Normalization
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Kit (Thermo
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CA, USA).
USA), Sequencing
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0 mismatches
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usingonthe
Illumina MiSeq
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2 × 300 bp
(IlluminaThe
Inc.,
analysis
was
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using
FLASh
software,
which
allowed
for
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the
reads
San Diego, CA, USA), and demultiplexing was based on 0 mismatches in the barcode sequences.
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The analysis
was300
performed
using FLASh
software,
for[25],
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[24].than
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removed using UCHIME [25], and sequences with low
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2.5. Sequence Statistical Analysis
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Figure 3. Weight reduction after bariatric surgery.
Figure 3. Weight reduction after bariatric surgery.
Table 2. ∆BMI after surgery in case of FUT2 variants.
Table 2. ΔBMI after surgery in case of FUT2 variants.
Fut2
n
Delta-BMI
SD

Fut2
AA
AAGA
GAGG
GG

n 2
Delta‐BMI
SD
−13.4000
3.1113
2 9
−13.4000
3.1113
−12.1571
4.9784
−13.8023
4.5286
9 8
−12.1571
4.9784
8
−13.8023
4.5286
Significance level
p = 0.77
Significance
p variants
= 0.77
SD: standard
deviation.level
AA, GA, GG: FUT2 gene

SD: standard deviation. AA, GA, GG: FUT2 gene variants
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Genetic examination showed that the majority of patients were FUT2 genes secretors (GA 47.4%
and GG 42.1%). Only 10.5% of the patients were non-secretors. In the study group, gastrointestinal
complaints persisted, which included: problems with emptying (26.3% of people suffered from
abdominal pain and recurrent diarrhea, while 36.8% had constipation), 26.3% had nausea and vomiting,
and 36.8% felt heartburn.
Analysis of 72 h diaries showed a very low dietary fiber intake in the study group (15.5 ± 6.4 g).
At the same time, the meals consumed by the patients were rich in protein, 65 ± 16.2 g (with a
predominance of animal protein over plant protein 44.89 ± 14 vs. 14.87 ± 5.68 g). The result of the
analysis of dietary logs is presented in Table 3.
Table 3. Seventy-two-hour nutritional diary log summary.
Energy (kcal)

Total Protein (g)

Animal Protein (g)

Plant Protein (g)

Fat (g)

1138 ± 366

65 ± 16.2

44.89 ± 14

14.87 ± 5.68 g

45.2 ± 18.8

Carbohydrates (g)
117.6 ± 44.9

Fiber (g)

Sucrose (g)

Sodium (mg)

Potassium (mg)

Calcium (mg)

Magnesium (mg)

15.5 ± 6.4

19.7 ± 12.4

1144 ± 544.5

2622 ± 774.4

497.2 ± 152.4

256.2 ± 88.5

Iron (mg)

Phosphorus (mg)

Zinc (mg)

Copper (mg)

Vitamin A (µg)

Vitamin D (µg)

8.9 ± 2.6

1008.3 ± 231.3

7.1 ± 1.8

1.03 ± 0.3

1311.9 ± 1671

3.2 ± 3.3

Vitamin E (mg)

Vitamin B1 (mg)

Vitamin B12 (µg)

Folate (µg)

Vitamin B6 (mg)

Vitamin C (mg)

7.7 ± 4

0.8 ± 0.3

5.7 ± 6.5

284.8 ± 148.1

1.6 ± 0.6

131.1 ± 92.4

± standard deviation.

3.2. Characteristics of the Stool Microbial Composition
Taxonomic compositions of the microbiota obtained from all the subjects were analyzed at the
phylum and genus levels, expressed as operational taxonomic units (OTUs) (Table 4). Three phyla
were present in all patients Firmicutes (22.78%), Bacteroidetes (60.75%), and Proteobacteria (16.47%).
Table 4. Composition of the microbiota.
Genus

Relative % Abundance (Cutoff > 1)

Haemophilus
Lachnospiracea_incertae_sedis
Phascolarctobacterium
Veillonella
Lactobacillus
Roseburia
Faecalibacterium
Blautia
Clostridium sensu stricto
Streptococcus
Oscillibacter
Barnesiella
Escherichia/Shigella
Parabacteroides
Alistipes
Prevotella
Bacteroides

1.10
1.26
1.35
1.42
1.64
1.87
1.88
1.95
2.05
2.19
2.62
2.68
4.31
4.69
9.71
12.29
26.40

Additionally, there were clear differences in the composition of the microbiome depending on the
FUT2 gene variant (Figures 4–7).
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Interestingly, there was a significant correlation (p = 0.01) between abundance of OTU’s with
two categorical factors: FUT2 gene variant (GA, AA, GG) and intolerance and two continuous
variables: waist‐to‐hip ratio (WHR) and propionic concentration. GG FUT2 carriers had a high
variables: waist-to-hip ratio (WHR) and propionic concentration. GG FUT2 carriers had a high
Prevotella and Escherichia. Shigella content increased with propionic concentration. In addition, in GG
Prevotella and Escherichia. Shigella content increased with propionic concentration. In addition, in GG
carriers, Bacteroides abundance increased with WHR. In turn, carriers of variant AA and GA had more
carriers, Bacteroides abundance increased with WHR. In turn, carriers of variant AA and GA had more
Enterobacteriaceae, Ruminococcaceae, Enterobacteriaceae, Clostridiales, and Bacteroidetes than GG (Figure
Enterobacteriaceae, Ruminococcaceae, Enterobacteriaceae, Clostridiales, and Bacteroidetes than GG (Figure 8).
8).
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with a change in intestinal microbiota and modification of the secretion of intestinal hormones [36].
It has been shown that increased concentration of propionate stimulates the secretion of anorexygenic
intestinal peptides—YY peptide hormone (PYY) and glucagon-like peptide-1 (GLP-1) from colon cells,
which in turn affects the feeling of satiety [37] and reduces the risk of weight gain.
In our study, however, we obtained the opposite results. Among the carriers of the GG variant of
the FUT2 gene, we observed an increase in both propionate and WHR levels (Figure 8). At this point,
it is worth mentioning that the BMI (BMI of our patients was 30.6 ± 5.3 kg/m2 ) is often used (due to its
simplicity and low cost) to assess body weight. However, the main disadvantage is the fact that it
does not allow one to determine the body composition (the proportion between fat and fat-free body
weight). In the context of health risks associated with excess body fat (especially metabolically active
visceral fat), WHR is a more precise indicator. Studies have shown that WHR is a better predictive
factor for visceral fat, cardiometabolic diseases, and mortality than BMI [38]. Therefore, the results of
our research can be extremely important in the context of the effectiveness of body fat reduction after
bariatric surgery.
In this study, the numbers of Prevotella, Escherichia, Schigella, and Bacteroides increased with the
increase in propionate and WHR. This is an interesting observation, as it is the reduced ratio of
Bacteroidetes to Firmicutes that is described as characteristic for obese individuals [39]. In addition,
studies of patients after bariatric surgery report a decrease in the number of Firmicutes and an
increase in Proteobacteria, Bacteroidetes, and Bacteroidetes/Firmicutes ratio. Additionally, in this group of
patients, the increase in the amount of Bacteroidetes correlates with fat reduction and weight loss [4,40].
The increase in the amount of Escherichia coli, in turn, is associated with greater efficiency in obtaining
energy in a state similar to starving after RYGB [41]. A frequently described phenomenon after bariatric
surgeries is also a decrease in the amount of Bifidobacterium [4]. It seems that a microbiome rich in
Bifidobacterium bacteria favors the preservation of homeostasis and the maintenance of normal body
weight (which has been confirmed in studies on animal models and in clinical studies on the human
population) [42–44]. The reason for the correlation with the increase in the WHR presented in our
study may be the increased production of short-chain fatty acids and their use as an additional source
of energy, as well as their indirect effect on metabolism. It has been shown that there are strains of
Bifidobacterium, e.g., B. longum, which have the ability to convert lactose to butyric acid [45]. In addition,
a higher abundance of Roseburia intestinales was found among the secretors, which is also responsible
for the intensive synthesis of this acid [13,14]. The majority of butyrate (about 70–90%) is used by
colonocytes as an energy source, however, the remaining amount is metabolized by the host and
constitutes an additional energy input obtained from potentially indigestible sources [46]. Additionally,
short-chain fatty acids can stimulate weight gain and adipogenesis in white adipose tissue by binding
to FFAR2 and FFAR3 (free fatty acid receptor) [47]. Interestingly, in our study, a similar relationship
was not found in carriers of the remaining variants of the FUT2 gene, which suggests that FUT2
secretors in the dominant homozygous type have a higher risk of ineffectiveness of bariatric surgery in
fat reduction than carriers of the recessive allele.
It is also important that although the patients were on average 3.2 years after surgery, their
BMI and WHR indices still indicated visceral obesity (I degree) and depressive disorders. The diet
used by the patients—high-protein, at the same time poor in dietary fiber, changes the characteristics
of bacterial fermentation and leads to intestinal dysbiosis [48]. Symptoms occurring in almost 30%
of our patients (such as recurrent abdominal pain, diarrhea, constipation) may be a manifestation
of disorders within the intestinal microflora that was previously described after RYGB [49].These
disorders negatively impact health-related quality of life because of effects on gastrointestinal motility,
visceral hypersensitivity, changes in gut permeability, immune activation, gut–brain dysregulation,
and central nervous system dysfunction [50]. In dysbiosis, the integrity of the intestinal barrier
(leaky gut syndrome), endotoxemia (i.e., penetration of fragments of the cell wall of Gram-negative
bacteria—lipopolysaccharide first to the area of the intestinal mucosa proper plate and then to
circulation) are disturbed. This phenomenon generates a state of local microinflammation (intestinal
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mucosa) which is dynamically transmitted throughout the body. It is the chronic low-intensity
inflammation that is responsible for the formation and progression of obesity, insulin resistance, and
generation of liver steatosis. Other mechanisms binding bacterial dysbiosis to obesity are negative
influences on the speed of intestinal passage, which makes it easier for bacteria to obtain energy from
intestinal contents more efficiently (in obese people, an increase in SCFAs content in stool, decrease in
lipolysis, and intensification of lipogenesis were found) [30].
5. Conclusions
The study suggests that the FUT2 gene variant may have a significant impact on the effectiveness
of visceral fat loss after bariatric surgery. Secretors (GG) as a result of increased levels of propionate,
which can be used as an additional source of energy for the body, may be less effective in reducing
their WHR than carriers of the other variants. Special attention should be paid to the balanced diet
of patients after surgery, so that apart from adequate protein, they also eat products rich in vitamins,
minerals, and fiber, which may reduce the risk of developing intestinal dysbiosis. Undoubtedly, there
is a need for further research on this subject.
6. Limitations
This study has several limitations worth noting. Although we stated that the number of patients
who met the inclusion criteria were 49, only 19 people were enrolled in this research. This undoubtedly
makes it necessary to repeat the study on a larger group of participants. Second, the patients were
recruited at the Surgical Obesity Surgery Outpatient Clinic in Szczecin Zdunowo, but due to its
outpatient nature, patients who have been operated on in different hospitals may be treated here (in this
research, 11 patients were operated on by the two surgeons from Zdunowo Hospital and 8 patients by
other surgeons). Thirdly, although all patients underwent laparoscopic SG or RYGB bariatric surgery,
they were operated on by different surgeons, which creates a risk of potential differences in surgical
techniques that could affect the results of this study.
This was an exploratory study without a prior power calculation. Therefore, it is necessary to
confirm these findings in future properly designed studies.
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